Genocea Biosciences (GNCA) PT Lowered to $10 at Needham & Company
Tweet
Share
E-mailGet Alerts GNCA Hot Sheet
Price: $0.05 --0%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
Needham & Company analyst Chad Messer lowered the price target on Genocea Biosciences (NASDAQ: GNCA) to $10.00 (from $16.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- The Magnum Ice Cream Company (MICC:NA) (MICC) PT Raised to EUR18.30 at UBS
- Needham Reiterates Buy Rating on Cerebras Systems (CBRS)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
